Transcranial magnetic stimulation (TMS) is a non-invasive, office-based procedure which was cleared by the FDA in 2008 and has been shown to be safe and effective for patients who fail to respond to antidepressant medications.
Physicians need to understand the concept of treatment-resistant depression, recognize its importance, know how to identify patients with treatment resistant illness, be aware of transcranial magnetic stimulation as an alternate treatment modality, and know when to refer patients for this treatment. Interested physicians may also consider adding TMS therapy to their own practices. This decision requires a thorough understanding of the devices that are available, the cost and logistical considerations involved with setting up a TMS practice, and the training required to safely and effectively administer the treatment.
The presentational method for this internet activity enduring material will be Case Presentation, Panel Discussion, Lecture with Q&A, Small Group Discussion/Roundtable, Hands-On Demonstration, and Simulated or live Patient. This activity is geared towards providers of clinical psychiatric care. This activity will encompass the following desirable physician attributes: Patient Care & Procedural Skills, Medical Knowledge, Professionalism, Interpersonal & communication Skills, and Practice-Based Learning & Improvement.
- Recognize the concept and significance of treatment resistant depression
- Effectively identify patients with treatment resistant depression
- Cite the role of TMS in treatment resistant depression
- Identify the mechanism of action of TMS
- Communicate the safety and efficacy of TMS
- Identify and refer appropriate patients for TMS
In accordance with the Americans with Disability Act (ADA), please call TMS Health Education at 844-867-8445 should you require special assistance.